Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT07262242Recruiting
Randomised, double-blind trial of Lidocaine Hydrochloride Injection, without epinephrine (2 arms), sponsored by Cairo University. Primary endpoint: Quality of Recovery-15 at 24 hours. Started Dec 2025; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT07262242.